UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001508 |
|---|---|
| Receipt number | R000001717 |
| Scientific Title | Osaka study of Nicorandil effect on Chronic Kidney Disease |
| Date of disclosure of the study information | 2009/01/10 |
| Last modified on | 2019/11/26 08:57:58 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/11/15 23:18:39 | ||
| 2 | Update | 2008/11/18 20:29:45 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2008/11/20 00:25:53 | Public title Acronym |
|
| 4 | Update | 2009/01/02 14:50:47 | Date of protocol fixation Anticipated trial start date |
|
| 5 | Update | 2009/01/26 15:46:06 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2009/10/09 12:38:49 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
| 7 | Update | 2009/10/09 12:39:58 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Institute |
|
| 8 | Update | 2009/10/09 12:40:31 | Recruitment status |
|
| 9 | Update | 2009/11/24 17:19:13 | Primary outcomes Primary outcomes Key secondary outcomes |
|
| 10 | Update | 2011/11/16 21:57:38 | Organization Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 11 | Update | 2014/06/10 04:20:54 | Email |
|
| 12 | Update | 2017/05/23 09:14:04 | Name of primary person or sponsor Organization |
|
| 13 | Update | 2019/11/24 13:59:39 | Recruitment status Date of IRB |
|
| 14 | Update | 2019/11/26 08:48:35 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Institute Department Organization Division Organization Organization Address Address Tel |
|
| 15 | Update | 2019/11/26 08:57:58 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
